Frontotemporal dementia (FTD) impinges markedly on everyday function^[@R1][@R2][@R3]^ but the degree and nature of functional disability depends on the clinical presentation. Specifically, a gradient of functional disability exists across the 3 primary clinical FTD subtypes: patients with behavioral variant FTD (bvFTD) are severely impaired, followed by nonfluent variant primary progressive aphasia (nfvPPA) and semantic variant primary progressive aphasia (svPPA).^[@R1],[@R4]^ Despite functional differences between bvFTD and svPPA, patients can share similar behavioral profiles; yet for patients with svPPA, this is often less noted due to the severe and prevalent language and semantic deficits.^[@R5],[@R6]^ nfvPPA, on the other hand, elicits a comparatively mild behavioral profile, and for this reason it was not included in the present study.

The nature of functional disability in FTD variants is likely to be a direct reflection of the specific behavioral and cognitive changes seen in each syndrome.^[@R2],[@R7]^ There is well-reported overlap of behavioral symptoms between bvFTD and svPPA.^[@R5],[@R6]^ It is critical to investigate the role of behavioral changes in functional disability; once independent factors are identified, novel interventions can be developed to reduce disability.

We hypothesized that similar levels of behavioral symptoms across bvFTD and svPPA would be present, but their specific contribution to functional disability would differ. The study aimed to (1) determine baseline function and behavior status in bvFTD and svPPA; (2) examine longitudinal functional and behavioral changes; and (3) examine relationships between functional and behavioral changes longitudinally.

METHODS {#s1}
=======

Participants {#s1-1}
------------

Thirty-nine individuals diagnosed with FTD (bvFTD = 21; svPPA = 18) and their caregivers were recruited from FRONTIER, the frontotemporal dementia research group based in Sydney, Australia. All patients met current criteria for either possible or probable bvFTD or svPPA^[@R8],[@R9]^ and diagnoses were based on a multidisciplinary consensus (neurologist and neuropsychologist). Study participants were assessed in the clinic, home, or care facility on 2--4 separate occasions approximately 16 months between each assessment (mean 16.4 ± 8.2) between November 2007 and January 2012, with 200 individual assessments completed in total.

Participants were included if they had a close relative or friend informant who could reliably report on the person\'s behavior and everyday routine, did not have major depression, and did not have any physical disability that could influence ability to undertake activities of daily living (ADLs). The ADL measure included in this study was not used in the diagnostic process. Disease duration was estimated from the onset of symptoms as described by the informant at the time of diagnosis.

Standard protocol approvals, registrations, and patient consents {#s1-2}
----------------------------------------------------------------

This study was approved by the University of New South Wales and the South Eastern Sydney and Illawarra Area Health Service human ethics committees. Written informed consent was obtained from each patient or primary caregiver where appropriate.

Instruments {#s1-3}
-----------

### Functional assessment {#s1-3-1}

ADLs were assessed with the Disability Assessment for Dementia (DAD),^[@R10]^ an informant-based scale made up of 17 items pertaining to basic ADLs and 23 to instrumental ADLs. Basic ADL items include hygiene, dressing, continence, and eating; instrumental ADL items include meal preparation, telephoning, going on an outing, finance and correspondence, medications, and leisure and housework. In order to avoid bias towards certain activities (e.g., meal preparation or housework), nonapplicable questions are omitted from the final score and the score is reported as a percentage. Greater impairment is indicated by lower DAD scores.

In order to further distinguish baseline clinical differences between the groups, basic ADL and instrumental ADL subscores were included in the analysis in addition to total DAD scores. All caregivers were interviewed by a research occupational therapist (EM or CO) at baseline and at each follow-up visit.

### Behavioral assessment {#s1-3-2}

The Cambridge Behavioural Inventory Revised (CBI-R)^[@R11]^ is a caregiver-completed assessment that comprises 45 items assessing behavior across 10 domains. Each question requires the caregiver to rate behavior on a 5-point scale (0 = never, 1 = a few times per month, 2 = a few times per week, 3 = daily, and 4 = constantly), with higher scores indicating higher frequency of abnormal behavior. Data for 4 behavioral subsections commonly associated with FTD^[@R9],[@R12],[@R13]^ were used: disinhibition (e.g., exhibiting socially embarrassing behavior; making inappropriate comments), stereotypical behaviors (e.g., adhering to rigid daily routines; being obsessive about watching the time), apathy (e.g., lacking motivation or enthusiasm; appearing indifferent), and eating changes (e.g., eating more sweet/fatty foods then before; declining table manners such as stuffing food into the mouth; eating an extremely restricted diet of specific foods). Subsection scores were converted to percentages to allow for domain comparison; higher scores represent greater behavioral change.

### General cognitive assessment {#s1-3-3}

At baseline, all participants were administered the Addenbrooke\'s Cognitive Examination Revised (ACE-R).^[@R14]^ The ACE is a brief screening tool sensitive to the early stages of dementia, which assesses 5 cognitive domains: attention and orientation, memory, verbal fluency, language, and visuospatial abilities. The total score is 100, where lower scores indicate more impaired cognitive functioning. The cutoff of 88/100 yields 89% specificity and 94% sensitivity for diagnosing dementia.

Data analyses {#s1-4}
-------------

Statistical analyses were performed using SPSS 21.0 (IBM, Armonk, NY) for Windows. Demographic data across both patient groups were compared using parametric independent sample *t* tests and χ^2^ tests for sex comparisons. Normality of distribution of baseline variables was assessed using Kolmogorov-Smirnov tests, and due to skewed data, nonparametric measures (Mann-Whitney *U*) were used for pairwise comparisons at baseline. To examine changes in function and behavior between the diagnostic categories over time, linear mixed-effect models were applied. Mixed model analyses allow for accounting for missing data,^[@R15]^ which was relevant in the current data, as the number of people who had follow-up assessments declined with each year. DAD data for bvFTD declined across the 4 visits as follows: n = 21, n = 16, n = 6, and n = 2; for svPPA: n = 18, n = 10, n = 10, and n = 4. CBI-R data for bvFTD declined across visits: n = 21, n = 20, n = 8, and n = 5; for svPPA: n = 18, n = 15, n = 11, and n = 5. Fixed effects in the model included time, diagnostic category (bvFTD or svPPA), and the interaction between time and diagnostic category. Individual patient variability at baseline was the only random effect included; hence a random intercept was included in each model. Both the fixed and random effects in the model determined the variability of any estimated parameters. Separate models were built for each of the following dependent variables: DAD total, DAD instrumental ADLs, DAD basic ADLs, CBI-R Disinhibition, CBI-R Stereotypical behavior, CBI-R Apathy, and CBI-R Eating changes. Due to the small sample size, a linear first-order polynomial was applied in the analysis. For any given model, a significant effect for time would indicate that the dependent variable changes over time, and a significant interaction between time and diagnostic category would indicate that bvFTD and svPPA have different changes in the dependent variable over time. To examine longitudinal relationships between behavioral variables and ADL function within groups, subject means for each CBI and DAD variable were calculated across observations. Pearson correlation was then calculated between these subject means and a weighted correlation coefficient was applied to account for the different number of observations across subjects.^[@R16]^ Bonferroni corrections were applied for multiple comparisons.

RESULTS {#s2}
=======

Demographics {#s2-1}
------------

The 2 clinical groups were matched for age, sex distribution, education, and disease duration. The bvFTD group scored higher than the svPPA group on global cognition ACE-R, reflecting the language load of this task ([table 1](#T1){ref-type="table"}).
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Baseline assessment {#s2-2}
-------------------

Pairwise comparisons revealed that patients with bvFTD scored lower than the svPPA group at baseline across all ADL scores ([table 1](#T1){ref-type="table"}) despite matched disease duration.

To investigate degrees of behavioral changes between groups, CBI-R percentage scores were categorized as absent (score = 0); mild/moderate (score = 1--50); or severe/very severe (score = 51--100). As shown in [figure 1, A and B](#F1){ref-type="fig"}, levels of disinhibition and stereotypical behavior were similar for bvFTD and svPPA. In contrast, patients with bvFTD had higher scores for apathy and eating changes, reflecting more marked neuropsychiatric changes in this subgroup ([table 1](#T1){ref-type="table"}). A striking group difference was detected in regards to apathy ([table 1](#T1){ref-type="table"}), where 71.5% of patients with bvFTD exhibited severe/very severe apathy compared with 33.3% of patients with svPPA ([figure 1C](#F1){ref-type="fig"}). Changes in eating behavior were present in 100% of patients with bvFTD, with half of them being reported as presenting with severe/very severe changes, whereas alterations in eating habits were reported in only 56% of patients with svPPA and the majority were mild/moderate changes ([figure 1D](#F1){ref-type="fig"}).

![Percentage distribution according to severity of baseline behavioral changes in behavioral variant frontotemporal dementia (bvFTD) and semantic variant primary progressive aphasia (svPPA) cohorts\
(A--D) Behavioral change absent, mild/moderate, or severe/very severe.](NEURCLINPRACT2016015156FF1){#F1}

Longitudinal changes {#s2-3}
--------------------

ADL function declined over time in both groups, with bvFTD worse than svPPA on all DAD scores: total ADLs (*F*~1,53.09~ = 79.30, *p* \< 0.001); instrumental ADLs (*F*~1,54.91~ = 48.78, *p* \< 0.001); and basic ADLs (*F*~1,52.92~ = 54.87, *p* \< 0.001). For basic ADLs specifically, patients with bvFTD exhibited a more rapid decline than patients with svPPA (*F*~1,52.92~ = 4.57, *p* \< 0.05; [figure 2C](#F2){ref-type="fig"}). Of note, the bvFTD group was near floor performance on the total DAD by year 3 ([figure 2A](#F2){ref-type="fig"}), while patients with svPPA were still performing at around 55% of ability in relation to their premorbid levels.

![Model representations of performance on functional and behavioral measures over time for behavioral variant frontotemporal dementia (bvFTD) and sematic variant primary progressive aphasia (svPPA) (plots model representations of scores)\
(A--G) ADL = activities of daily living; BADL = basic activities of daily living; CBI = Cambridge Behavioural Inventory; DAD = Disability Assessment for Dementia; IADL = instrumental activities of daily living.](NEURCLINPRACT2016015156FF2){#F2}

Longitudinal changes in levels of disinhibition (*F*~1,72.84~ = 11.05, *p* \< 0.005) and stereotypical behavior (*F*~1,72.46~ = 11.28, *p* \< 0.005) differed between bvFTD and svPPA despite the 2 groups showing similar levels on these measures at baseline. svPPA demonstrated increasing levels of these behaviors over time, whereas both behaviors declined in bvFTD ([figure 2, D and E](#F2){ref-type="fig"}). Levels of apathy (*F*~1,75.34~ = 16.61, *p* \< 0.001) and eating changes (*F*~1,74.68~ = 26.79, *p* \< 0.001) increased at a similar rate over time for both groups; however, patients with bvFTD continued to exhibit higher levels of these behaviors than patients with svPPA ([figure 2, F and G](#F2){ref-type="fig"}).

Longitudinal correlations {#s2-4}
-------------------------

Pearson correlations using subject means and weighted correlation coefficients were conducted to examine relationships between decline in ADL function (DAD subscores) and behavioral changes (CBI behavioral scores) over time ([table 2](#T2){ref-type="table"}). For bvFTD, decline in both total ADL and instrumental ADL scores were associated with apathy (*r* = −0.512, *p* \< 0.001; *r* = −0.586, *p* \< 0.001), while decline in basic ADLs was correlated with stereotypical behavior (*r* = 0.329, *p* \< 0.015). For svPPA, apathy correlated with both total ADLs (*r* = −0.514, *p* \< 0.005) and instrumental ADLs (*r* = −0.583, *p* \< 0.001).
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DISCUSSION {#s3}
==========

Marked overlapping behavioral changes in bvFTD and svPPA dissociate over time: behavioral changes become less pronounced in bvFTD but increase in svPPA. Importantly, decline in everyday function was associated with increased apathy in bvFTD and svPPA. Stereotypical behavior and ADL decline was only associated with disability in patients with bvFTD, despite comparable levels of stereotypical behavior at baseline in both groups. In comparison, disinhibition per se did not seem to make a direct contribution to functional decline over time for either group. Taken together, our results confirm previous findings of more severe functional impairment in bvFTD than in svPPA, and we confirmed that this difference in functional status continues as the disease progresses.

The correlation between apathy and worsening function demonstrated in both bvFTD and svPPA is perhaps not surprising given that as apathy increases, a person is less likely to participate in daily activities. This association has also been reported in Alzheimer disease (AD), where apathy, anxiety, and aberrant motor disturbance correlate with functional disability.^[@R17][@R18][@R19]^ The longitudinal link between apathy and functional decline in bvFTD reported here also supports findings from previous cross-sectional studies.^[@R2],[@R7]^

Across both patient groups, disinhibition did not play a major role in functional impairment. By contrast, apathy, sometimes regarded as the flip side of disinhibition, was detrimental to functional activities as patients failed to initiate them. In the present study, apathy and changes in eating habits continue to increase throughout progression in both bvFTD and svPPA. In contrast, disinhibited and stereotypical behaviors, which are often difficult to manage, ameliorate over time in bvFTD while continuing to worsen in svPPA. A possible reason for this may be the differing rates of disease progression: patients with bvFTD decline faster into frank apathy, which may restrict the concurrent expression of other symptoms, while patients with svPPA have a protracted disease progression. Past studies have reported a pattern of behavioral fluctuation over time in bvFTD, where patients may became more docile and compliant as some challenging behaviors disappear throughout disease progression,^[@R20]^ or new behaviors appear in later stages.^[@R6],[@R21][@R22][@R23]^ Comparable findings of behavioral fluctuations along dementia progression have been described in the AD dementia literature,^[@R24],[@R25]^ reflecting the complex nature of neuropsychiatric symptoms in neurodegenerative diseases.

The contribution of stereotypical behaviors to function seems to vary in bvFTD and svPPA. In bvFTD, decline in stereotypical behaviors was associated with a reduction of participation in basic daily functions. This association was not detected in svPPA, possibly due to the noteworthy increase of these behaviors over time. In fact, our results suggest that the presence of stereotypical behaviors may serve as a compensatory support for continued participation in rigid self-care routine tasks in patients with svPPA, which in turn show very mild decline even after 4 years.^[@R26],[@R27]^ Closer examination at the specific dysfunctional behaviors reveals that the nature of stereotypical behaviors is different. Patients with bvFTD are more likely to exhibit impulsive behaviors, such as clapping or counting aloud, whereas patients with svPPA are prone to adhere to a rigid routine and clock-watching.^[@R28],[@R29]^ Similarly, longitudinal changes in eating habits in svPPA seem to mirror their stereotypical behavior: rigid routines and bizarre choices around food commonly develop within the first few years in svPPA.^[@R27],[@R30][@R31][@R32]^ Overeating is a common early feature in bvFTD and more so than in svPPA,^[@R33]^ which may be more related to lack of inhibitory control. An interesting question for future research would be to confirm if the rigid/compulsive nature of svPPA behaviors is more conducive to ADL performance, in particular for basic activities. Indeed, patients with svPPA remain relatively independent in everyday tasks for a much longer period of time, in line with a much more protracted disease progression.^[@R4],[@R34],[@R35]^

With disease progression, substantial overlap between FTD clinical variants arises, where merging clinical characteristics between bvFTD and svPPA have been well-described.^[@R23],[@R36]^ Findings from this study highlight the early overlap of behavioral changes in both subgroups, which has a direct repercussion on family caregiver burden^[@R37]^ that increases noticeably in svPPA.^[@R38]^

This study has some limitations, including the relatively small numbers of participants, with declining numbers at each follow-up visit. Attrition of participants at follow-up is a common phenomenon as patients become too impaired to return to research centers, and the small numbers included in this study could limit the generalizability of the results. The primary reasons behind attrition were participants becoming too impaired to be followed up at the annual visits or participants\' death. The use of the mixed model analysis provided more flexibility around this limitation in the data. The use of informant report measures could be a potential bias if caregivers underreport or overreport functional abilities and behaviors,^[@R39]^ but other studies have shown a great benefit of using them with bvFTD groups.^[@R40]^

Overlapping marked behavioral changes are very well known in bvFTD and perhaps currently less emphasized in svPPA.^[@R12]^ The present study offers novel insights into their distinct progression as well as diverse contribution to functional decline, where apathy is a clear negative contributor to disability to both bvFTD and svPPA. This finding alone has clinical implications, as apathy could be an important consideration in the development of interventions to improve functional performance in patients with FTD. Other factors underpinning disability in svPPA are yet to be further investigated, but our findings suggest that the development of treatments to slow functional decline in FTD (pharmacologic and nonpharmacologic) will need to consider the specific contributions of neuropsychiatric symptoms to disability.
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